Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 2Phase 1/2 2Phase 4 1Phase 2/3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 118INDUSTRY 105NIH 16NETWORK 8OTHER_GOV 3UNKNOWN 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 1Esophageal Neoplasms 1

Interventions

Paclitaxel 3S 1 (combination) 2Oxaliplatin 2Irinotecan 2Cisplatin 2Capecitabine 2titanium silicide 1nedaplatin 1anlotinib 1Radiation 1Pemetrexed 1Lenalidomide 1HMPL-013 1Gemcitabine 1Esophagectomy 1Clinical Trials, Phase II as Topic 1Clinical Trials, Phase I as Topic 1Carboplatin 1Bevacizumab 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × UNKNOWN × Cisplatin × Clear all
NCT03639467 2018-09-18

Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma

ChineseAMS

Phase 1/2 Unknown
40 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT02446574 2017-10-24

Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma

ChineseAMS

Phase 1/2 Completed
33 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡